NCT05076253View on ClinicalTrials.gov

Efficacy of Ivermectin in COVID-19

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
SafetySARS-CoV2 InfectionIvermectin PoisoningEffect of Drug
Interventions
DRUG

Ivermectin

Ivermectin plus standard care

DRUG

Placebo

Standard care

Trial Locations (1)

10300

Thananda Trakarnvanich, Bangkok

All Listed Sponsors
lead

Bangkok Metropolitan Administration Medical College and Vajira Hospital

OTHER_GOV

NCT05076253 - Efficacy of Ivermectin in COVID-19 | Biotech Hunter | Biotech Hunter